Toshiba America Medical Systems has sharply focused its U.S. ultrasoundproduct efforts. The vendor has ended the sales of scanners intosuch markets as ob/gyn and urology--which were channeled throughdealers--in order to focus its own direct sales efforts
Toshiba America Medical Systems has sharply focused its U.S. ultrasoundproduct efforts. The vendor has ended the sales of scanners intosuch markets as ob/gyn and urology--which were channeled throughdealers--in order to focus its own direct sales efforts on radiologyand cardiology, according to Daniel Dugan, vice president forultrasound business operations.
"We cover the (U.S.) market with dedicated ultrasoundpeople and no distributors," Dugan told SCAN.
Trimming its product line will help TAMS avoid customer confusionabout what scanners are meant for which markets. The strategywill also let the vendor concentrate ultrasound advertising, marketingand sales resources on the two dominant user groups in this market,he said.
"We may come back to the ob/gyn market, for instance,but with a product designed and built for the U.S. market anda dedicated organization set up to sell it," Dugan said.
TAMS has expanded its ultrasound sales and service staff tofocus on these two large market segments. Although some short-termrevenue was sacrificed by the shift of products, overall ultrasoundrevenue will have grown 45% to 50% in fiscal 1991 (end-March).This makes TAMS the fastest growing ultrasound company in theU.S., he said.
Toshiba is readying the seventh software revision for its 270high-end ultrasound scanner, which should be available by May.A unique feature of the upgrade is independent beam steering forgray-scale imaging, spectral Doppler and color-flow Doppler, saidThomas Jedrzejewicz, director of marketing.
Gray-scale imaging is optimized when the beam runs perpendicularto the vessel. However, vessels do not always run parallel tothe skin, he noted. Color-flow Doppler, on the other hand, requiresits own approach to the vessel for optimization of the flow velocitymap.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.